SG

Sahil Gupta

Active Director Director DIN 09288531
DIN 09288531 First appointment Aug 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value •••• Premium profile

About Sahil Gupta

Data last updated:

Sahil Gupta is a Director at Cosmo Life Saving Drugs Private Limited (since 2021). The company operates in Pharma. Cosmo Life Saving Drugs Private Limited reported revenue of ₹49.5 Lakh (FY 2025).

DIN 09288531
Primary Designation Director
Industry Pharma
First Appointment 20 Aug 2021
Oldest Company Age 5 yrs
Largest company Cosmo Life Saving Drugs Private Limited · ₹49.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Aug 20212021₹49.5 Lakh (FY 2025)Active

Board colleagues of Sahil Gupta

NameDINCompanyDesignation
Sneh Lata Gupta09288532Cosmo Life Saving Drugs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Cosmo Life Saving Drugs Private Limited
Premium access

Shareholding and investment profile for Sahil Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sahil Gupta

Sahil Gupta currently holds 1 directorship: Cosmo Life Saving Drugs Private Limited (Director, since 20 Aug 2021, revenue ₹49.5 Lakh (FY 2025)).

Sahil Gupta was first appointed on 20 Aug 2021 as Director at Cosmo Life Saving Drugs Private Limited.

The current boards of Sahil Gupta's companies include Sneh Lata Gupta (Cosmo Life Saving Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available